Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Cerus Corporation CERS
$1.89
-$0.06 (-3.33%)
На 18:00, 12 мая 2023
Ранг: 2
Ключевые показатели
-
Marketcap
357492960.00000000
-
week52high
5.95
-
week52low
1.98
-
Revenue
162048000
-
P/E TTM
-9
-
Beta
1.03252500
-
EPS
-0.22000000
-
Last Dividend
0.00000000
-
Next Earnings Date
04 мая 2023 г. в 20:00
Описание компании
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was incorporated in 1991 and is headquartered in Concord, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Stifel | Buy | Buy | 27 мая 2020 г. |
| Stephens & Co. | Overweight | Overweight | 16 апр 2020 г. |
| BTIG Research | Buy | 26 февр 2020 г. | |
| BTIG Research | Buy | Neutral | 13 ноя 2019 г. |
| Stifel | Buy | Buy | 28 авг 2019 г. |
| BTIG | Buy | 26 февр 2020 г. | |
| BTIG | Neutral | Buy | 20 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Swisher Daniel N JR | D | 0 | 12500 | 10 ноя 2022 г. |
| Swisher Daniel N JR | D | 113808 | 12500 | 10 ноя 2022 г. |
| Swisher Daniel N JR | A | 126308 | 12500 | 10 ноя 2022 г. |
| Menard Chrystal | D | 164871 | 10000 | 15 авг 2022 г. |
| Benjamin Richard J | D | 172665 | 10000 | 09 авг 2022 г. |
| Shan Hua | A | 58074 | 58074 | 01 июл 2022 г. |
| Shan Hua | A | 29886 | 29886 | 01 июл 2022 г. |
| Witney Frank | A | 39866 | 39866 | 01 июн 2022 г. |
| Witney Frank | A | 120059 | 20454 | 01 июн 2022 г. |
| SCHULZE GAIL | A | 39866 | 39866 | 01 июн 2022 г. |
Новостная лента
Cerus Corporation: Cash Burn Remains Concerning
Seeking Alpha
10 мая 2023 г. в 15:41
Today, we put medical device concern Cerus Corporation in the spotlight. Cerus has some current challenges, which management believes are temporary. Sales growth is projected to accelerate significantly in FY2024.
Cerus (CERS) Reports Q1 Loss, Lags Revenue Estimates
Zacks Investment Research
04 мая 2023 г. в 19:01
Cerus (CERS) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.07 per share a year ago.
7 Best Cathie Wood Stocks for Your May 2023 Buy List
InvestorPlace
02 мая 2023 г. в 12:25
Cathie Wood invests in speculative stocks that don't always pan out, as 2022 showed. The chief of Ark Investment Management watched her firm outperform in 2021, though last year saw a sharp deceleration in interest in various hough-growth names.
Cerus Corporation to Release First Quarter 2023 Financial Results on May 4, 2023
Business Wire
20 апр 2023 г. в 08:30
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today that its first quarter 2023 financial results will be released on Thursday, May 4, 2023, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discuss the Company's financial results and provide a general business overview and outlook.
Cerus Corp (CERS) Q4 2022 Earnings Call Transcript
Seeking Alpha
28 февр 2023 г. в 23:51
Cerus Corp (NASDAQ:CERS ) Q4 2022 Earnings Conference Call February 28, 2023 4:30 PM ET Company Participants Joel Trujillo - Senior Director, IR William Greenman - President, CEO & Director Vivek Jayaraman - COO Kevin Green - VP, Finance & CFO Carol Moore - SVP, Regulatory Affairs, Quality & Clinical Conference Call Participants Mathew Blackman - Stifel, Nicolaus & Company Jacob Johnson - Stephens Inc. Brandon Folkes - Cantor Fitzgerald Joshua Jennings - Cowen and Company Operator Good day, ladies and gentlemen. Thank you for standing by, and welcome to the Cerus Corporation Fourth Quarter and Full Year 2022 Earnings Conference Call.